08.04.22

Chimeric Anti-GPC3 sFv-CD3ε Receptor-Modified T Cells with IL7 Co-Expression for the Treatment of Solid Tumors" Molecular Therapy — Oncolytics

Theme picker

ASTCT Publications

Join ASTCT

Follow Us on Twitter

Pharmacy SIG Literature Update: Post-transplant cyclophosphamide for prevention of acute graft versus host disease

08.03.22

Pharmacy SIG Literature Update: Post-transplant cyclophosphamide for prevention of acute graft versus host disease

by ASTCT Pharmacy SIG Research Working Committee

Long-Term Patient-Reported Neurocognitive Outcomes in Adult Survivors of Hematopoietic Cell Transplant

08.02.22

Long-Term Patient-Reported Neurocognitive Outcomes in Adult Survivors of Hematopoietic Cell Transplant

by ASTCT Science Highlights

Prospective External Validation of Biomarkers to Predict Acute Graft-Versus Host Disease Severity

07.21.22

Prospective External Validation of Biomarkers to Predict Acute Graft-Versus Host Disease Severity

by ASTCT Science Highlights

$Comparative Effectiveness of ZUMA-5 (Axi-Cel) vs SCHOLAR-5 External Control in Relapsed/Refractory Follicular Lymphoma$

07.19.22

Comparative Effectiveness of ZUMA-5 (Axi-Cel) vs SCHOLAR-5 External Control in Relapsed/Refractory Follicular Lymphoma

by ASTCT Science Highlights

The Times They Are A-Changin’

07.12.22

The Times They Are A-Changin’

by Brenda M. Sandmaier, MD

Dual-Specific CAR T Cell Expansion Improves Efficacy Against Solid Tumors in Mice

07.07.22

Dual-Specific CAR T Cell Expansion Improves Efficacy Against Solid Tumors in Mice

by ASTCT Science Highlights

Theme picker

Thank you to our sponsors

Amgen

pharmacyclics